Vaxxinity (VAXX) IPO Opens 30% Higher

Today's IPO for Vaxxinity, Inc. (NASDAQ: VAXX) opened for trading at $16.90 after pricing 6,000,000 shares of class A common stock at a public offering price of $13.00 per share.

BofA Securities, Jefferies and Evercore ISI. are acting as lead book-running managers for the offering.

Vaxxinity, Inc. is a U.S.-based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. The company’s proprietary technology platform has enabled the innovation of synthetic peptide-based candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia. The technology is also implemented as part of a COVID-19 vaccine program. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health.

You May Also Be Interested In

• SK hynix files for Nasdaq IPO under ticker symbol SKHY
• UK’s EG Group reportedly files for US IPO worth about $1 billion
• Absci prices $100M stock offering with Eli Lilly among investors